The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 13, 2015

Filed:

Jun. 15, 2011
Applicants:

Matthias Eckhardt, Biberach an der Riss, DE;

Frank Himmelsbach, Mittelbiberach, DE;

Katerina Leftheris, San Diego, CA (US);

Suresh B. Singh, Kendall Park, NJ (US);

Colin M. Tice, Ambler, PA (US);

Zhenrong Xu, Chalfont, PA (US);

Yuanjie YE, Ambler, PA (US);

Linghang Zhuang, Chalfont, PA (US);

Inventors:

Matthias Eckhardt, Biberach an der Riss, DE;

Frank Himmelsbach, Mittelbiberach, DE;

Katerina Leftheris, San Diego, CA (US);

Suresh B. Singh, Kendall Park, NJ (US);

Colin M. Tice, Ambler, PA (US);

Zhenrong Xu, Chalfont, PA (US);

Yuanjie Ye, Ambler, PA (US);

Linghang Zhuang, Chalfont, PA (US);

Assignees:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 413/14 (2006.01); C07D 413/12 (2006.01); C07D 413/10 (2006.01); A61K 31/5355 (2006.01);
U.S. Cl.
CPC ...
Abstract

Disclosed are compounds represented by Formula (I): or pharmaceutically acceptable salts, enantiomers or diastereomers thereof. Also disclosed are pharmaceutical compositions comprising the compounds of Formula (I) or pharmaceutically acceptable salts, enantiomers or diastereomers thereof for the therapeutic treatment of diseases associated with the modulation or inhibition of 11β-HSD1 in mammals. Values for the variables of Formula (I) are defined herein.


Find Patent Forward Citations

Loading…